Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer
Cancer. 2011;117(13):2830-2832 
43 oral A retrospective comparison of the use of androgen deprivation among low and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
Radiotherapy and Oncology. 2004;71:S21
Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
Radiation Oncology Journal. 2021;39(3):231-238
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer: Why EBRT+ADT remains the gold standard
Reports of Practical Oncology & Radiotherapy. 2013;18:S102
Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
Urologic Oncology: Seminars and Original Investigations. 2004;22(4):378
The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study
Urologia Internationalis. 2021;1-9
21 oral External beam irradiation (XRT) is inferior to high dose rate brachytherapy in combination with XRT or radical prostatectomy in treating localised prostate cancer (PC)
Radiotherapy and Oncology. 2003;66:S9
PV-0629: External beam RT with brachytherapy vs prostatectomy in treatment of high-risk prostate cancer
Radiotherapy and Oncology. 2018;127:S334-S335
A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
Urologic Oncology: Seminars and Original Investigations. 2005;23(4):305
Re: Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9–10 Prostate Cancer
European Urology. 2018;74(4):526